Deployment addresses the $1 billion antibody-reproducibility crisis by enabling rapid, objective validation of research reagents, reducing wasted time and cost in research and drug development.

The MarketWatch News Department was not involved in the creation of this content. New patent-pending technology helps creators reduce risk and make smarter creative decisions before content goes live.

Vanderbilt quarterback Diego Pavia expressed frustration on Instagram after finishing second in the Heisman Trophy voting. Pavia later apologized for his post, which was directed at the Heisman voters ...

Whomever said, "Sticks and stones may break my bones, but words will never hurt me," never met Vanderbilt's outspoken, Heisman runner-up quarterback Diego Pavia. Pavia's words after finishing second ...

GERMANTOWN, MD AND CHICAGO, IL / ACCESS Newswire / December 16, 2025 / uBriGene Biosciences, a leading global lentivirus CDMO specializing in Advanced Therapy Medicinal Product (ATMP) GMP development ...

Should you have feedback on this article, please complete the fields below. Please indicate if your feedback is in the form of a letter to the editor that you wish to have published. If so, please be ...

Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announces the official launch of the ...

The carrier’s Connected Life platform, now available nationwide, lets AT&T customers easily set up a smart home security system. Previously available as a pilot program in select markets, AT&T ...

Lucas is a writer and narrative designer from Argentina with over 15 years of experience writing for games and news. He keeps a watchful eye at the gaming world and loves to write about the hottest ...